Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) Return on Capital Employed (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Return on Capital Employed for 4 consecutive years, with 0.28% as the latest value for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 14.0% year-over-year to 0.28%; the TTM value through Dec 2025 reached 0.28%, up 14.0%, while the annual FY2025 figure was 0.26%, 27.0% up from the prior year.
  • Return on Capital Employed was 0.28% for Q4 2025 at Day One Biopharmaceuticals, up from 0.36% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.24% in Q2 2025, with the low at 1.08% in Q2 2024.
  • Historically, Return on Capital Employed has averaged 0.49% across 4 years, with a median of 0.46% in 2024.
  • The largest annual shift saw Return on Capital Employed plummeted -59bps in 2024 before it skyrocketed 85bps in 2025.
  • Over 4 years, Return on Capital Employed stood at 0.42% in 2022, then plummeted by -34bps to 0.56% in 2023, then grew by 26bps to 0.42% in 2024, then surged by 32bps to 0.28% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.28% in Q4 2025, 0.36% in Q3 2025, and 0.24% in Q2 2025.